If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Trulicity® (dulaglutide) be used in patients with type 1 diabetes?
Trulicity is not approved for use in patients with type 1 diabetes.
See important safety information, including boxed warning, in the attached prescribing information.
Trulicity is an injectable prescription medicine that is used
- along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes, and
- to reduce the risk of major adverse cardiovascular events such as death, heart attack, or stroke in adults with type 2 diabetes with known heart disease or multiple cardiovascular risk factors.1
Trulicity and Type 1 Diabetes
Trulicity should not be used in patients with type 1 diabetes.2
Trulicity is not approved for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as the safety and efficacy of Trulicity in these patient populations have not been studied.3
Trulicity is not a substitute for insulin.3
Enclosed Prescribing Information
1Trulicity [medication guide]. Indianapolis, IN: Eli Lilly and Company; 2022.
2Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2022.
3Data on file, Eli Lilly and Company and/or one of its subsidiaries.
Date of Last Review: July 01, 2022